Bruker Corporation

US$61.31As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BRKRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 11.99%
Div yield 0.33%
ROE (4.79%)
Medical Devices
Beta (5Y) 1.27
PE TTM —
TSR TTM 58.11%
Mkt cap US$9.363B
ROIC 7.99%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$67
9.72%
53.06%
Hold 11|3|1|7|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.58
0.64
0.66
0.66
(4.43%)
5.53%
9.42%
11.47%
Revenue$M
503.8
518.9
503.9
491.3
2.10%
6.55%
6.27%
2.54%
Peers (US$9.363B)
Cap (US$)
PE
10.16B
23.90x
9.412B
17.50x
7.903B
32.38x
Capital
TTM
5Y
10Y
Leveragex
1.784
1.860
1.400
EBIT/Intx
0.203
0.794
0.516
Own earn%
(71.92)
(43.95)
(42.97)
Sh yield%
33.76
27.20
26.92
Owners
Insiders/Inst%
4.69
69.01
Short interest%
2.95
SBC / revenue%
1.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
1–5
$1 testx
—
Incr. ROIC%
4